Home / Intelligence / News

Search

NEW ANNUAL DIGITAL COMPETENCY REPORT ASSESSES 124 IN-MARKET BIOPHARMA PATIENT BRANDS THROUGH THE LENS OF DIGITAL EXECUTION

Waltham, MA, December 2, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, launched its inaugural TGaS 2021 Digital Competency Report assessing 124 biopharma patient brands through the lens of digital execution. The novel study evaluates the brands across five categories and 40 unique metrics to understand each one’s digital presence. The Digital Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of spend, time in market, therapeutic areas, and…

Read Now

TRINITY LIFE SCIENCES RECAPITALIZES WITH KOHLBERG & COMPANY

Global Expansion, New Innovative Offerings Will Continue To Be the Focus for the Company Waltham, MA, November 30, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced today the signing of a definitive agreement for a recapitalization transaction led by Kohlberg & Company, a leading private equity firm with more than 30 years of experience. Trinity has been partnered with Parthenon Capital since early 2018 to rapidly grow its team, capabilities and global footprint. This…

Read Now

TRINITY LIFE SCIENCES FORMALIZES FULL OFFERING OF COMMERCIALIZATION SERVICES FOR MEDICAL TECHNOLOGY COMPANIES WITH NEW CENTER OF EXCELLENCE

Inflection Point in the MedTech Industry as Companies Pivot from Sales Force-focused to Data-driven Webinar entitled “MedTech in the Post-COVID World: Where Do We Go from Here” Scheduled for October 28 Waltham, MA, October 25, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a full offering of commercialization services for medical technology (MedTech) companies with the launch of their new MedTech Center of Excellence. Trinity has a been working with MedTech companies since its…

Read Now

TRINITY LIFE SCIENCES FORMS PARTNERSHIP WITH FORIAN

Trinity EvidenceFirst™ Allows Life Science Companies to Make Evidence-based Decisions Across an Asset’s Lifecycle with Forian Real World Data Insights Waltham, MA, October 12, 2021 — Trinity Life Sciences, a leader in global life sciences solutions, announces a new partnership that enables Trinity EvidenceFirst to unlock streamlined, integrated insights using Forian’s real-world data (RWD) products. Trinity’s experts leverage EvidenceFirst, a suite of real-world evidence (RWE) offerings, to help pharma, biotech, and medtech companies steer through the complexities of RWD analysis.…

Read Now

TRINITY LIFE SCIENCES ACQUIRES CBPARTNERS

Acquisition Significantly Bolsters Trinity’s Value, Access and Pricing Business Waltham, MA, October 7, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of New York-headquartered CBPartners. The acquisition significantly scales Trinity’s Value, Access and Pricing business, adding over 75 dedicated experts to the Company. This level of depth and breadth in market access gives Trinity a leading position in the life sciences industry. The combination of Trinity’s commercial strategy and solutions, augmented by…

Read Now

TRINITY LIFE SCIENCES PARTNERS WITH KOMODO HEALTH

With Komodo’s Healthcare Map, Trinity EvidenceFirst™ Steers Through the Complexities of Real-World Evidence Analysis to Yield High-Impact Insights Waltham, MA, Sept 15, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced a partnership with Komodo Health that will unlock unique, valuable insights in combination with Trinity’s EvidenceFirst. Trinity’s experts leverage EvidenceFirst, a suite of real-world evidence (RWE) offerings, to help pharma, biotech, and medtech companies navigate to strategic, data-informed decisions across an asset’s lifecycle.…

Read Now

TRINITY LIFE SCIENCES NAMED TO THE INC. 5000 LIST

Waltham, MA, August 30, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has been included on Inc. magazine’s annual Inc. 5000 list, the most prestigious ranking of the United States’ fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment – its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on…

Read Now

Seventy-Four Percent of Pharmaceutical Marketing Executives Say Changes in Third-Party Cookie Management Will be Impactful or Very Impactful on Their Media Plans

Waltham, MA, June 16, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS Advisors’ brief entitled Changes in Third-Party Cookie Management and Their Effects on Pharmaceutical Brands. The paper finds that although most respondents did not have a clear understanding of the changes in third-party cookie management, 74 percent of pharma marketing executives say the changes will be impactful or very impactful on their media plans. However, less than…

Read Now

Fourth Annual Best of Benchmark Award Winners Announced

The Awards are Given for Commercial Operations Excellence within the Pharmaceutical Industry Waltham, MA MAY 6, 2021 – Trinity Life Sciences, a leader in global life science commercialization solutions, announced the winners of the TGaS Best of Benchmark (BoBs) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at AbbVie, Biogen, Genentech, Lundbeck, Otsuka, Pharmacyclics and Janssen Biotech, Inc. The BoBs are based on TGaS benchmarking of large, midsize, and emerging life…

Read Now

While There are Still Unknowns, Monoclonal Antibodies Can Help in the Fight Against COVID-19

Antibodies have the Potential to Effectively Target Several Stages of the Disease with Evident Benefits at a Patient Level and a Systemic Level, According to a New White Paper by Trinity Life Sciences Waltham, MA, May 3, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest white paper entitled “Beyond Vaccines – How Monoclonal Antibodies Can Help in the Fight Against the COVID-19 Pandemic.” The paper finds that while there are still unknowns…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.